Durable response to pembrolizumab in microsatellite instability‐high advanced adrenocortical carcinoma

Introduction Advanced adrenocortical carcinoma has a poor prognosis and is treated with chemotherapy that includes mitotane with etoposide, doxorubicin, and cisplatin as first‐line therapy. However, second‐line therapy has not been determined yet. Pembrolizumab has been approved for high microsatell...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Masaya Senda, Kohei Hashimoto, Tetsuya Shindo, Ko Kobayashi, Toshiaki Tanaka, Naoya Masumori
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2023-11-01
Sarja:	IJU Case Reports
Aiheet:	adrenocortical carcinoma microsatellite instability mitotane pembrolizumab tumor‐agnostic treatment
Linkit:	https://doi.org/10.1002/iju5.12628
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!